Novo Industries of North America

Symbiance is a clinical research organization that provides a range of statistical services. It offers various clinical trial management, monitoring and biostatistics services. The organization also provides several medical writing solutions, such as updating, reporting and submitting. Symbiance offers a range of data and site management, implementation, strategic planning and regulatory services. Additionally, it provides consulting services for study design, statistical methodology and analysis issues. Symbiance maintains a staff of data management personnel, statisticians and computer programmers. It offers protocol development and database preparation services, as well as provides assistance with the analysis and interpretation of clinical data. The organization is headquartered in Princeton Junction, N.J.

CHDI Foundation is a privately-funded nonprofit biomedical research organization dedicated to accelerating the development of therapeutics for Huntington's disease (HD). By fostering collaboration among a diverse portfolio of research projects, CHDI aims to bridge the translational gap between academic and industrial research, ensuring faster access to innovative therapies for patients. With a global network of over 700 researchers and partnerships with biotech and pharmaceutical companies, CHDI provides essential resources such as clinical data, biosamples, and animal models to the HD research community. Its comprehensive approach includes managing the Enroll-HD clinical research platform, which has enrolled over 28,000 participants worldwide, facilitating smarter clinical trial designs and improved care for HD patients. Generated from the website

Sandoz, a Novartis company, with global headquarters in Vienna, Austria, is a world leader in generic pharmaceuticals and develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients. Decades of experience make Sandoz a renowned partner in pharmaceuticals, biopharmaceuticals and anti-infectives. Sandoz reported sales in 2004 were $3 billion and employed approximately 13,400 people in more than 110 countries. Sandoz is a leading global supplier of high-quality generic pharmaceuticals. A generic pharmaceutical product is the bioequivalent of a brand name pharmaceutical. This includes dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Generic pharmaceuticals are held to the same rigid standards as the innovator product, as dictated by the U.S. Food and Drug Administration and other regulatory agencies throughout the world. Although generic pharmaceuticals are chemically identical to their branded counterparts, they traditionally cost consumers less than the brand product.